Abuse, dependency and withdrawal with gabapentin: a first case report.
Victorri-Vigneau
C
C
Guerlais
M
M
Jolliet
P
P
D000368:Aged; D000437:Alcoholism / Q000150:complications / Q000188:drug therapy / Q000523:psychology; D000588:Amines / Q000008:administration & dosage / Q000009:adverse effects*; D018692:Antimanic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003509:Cyclohexanecarboxylic Acids / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D000077206:Gabapentin; D006801:Humans; D019964:Mood Disorders / Q000150:complications / Q000188:drug therapy / Q000523:psychology; D013375:Substance Withdrawal Syndrome / Q000503:physiopathology / Q000523:psychology*; D019966:Substance-Related Disorders / Q000523:psychology*; D005680:gamma-Aminobutyric Acid / Q000008:administration & dosage / Q000009:adverse effects*
D000588:Amines; D018692:Antimanic Agents; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin